1. Home
  2. XBIO vs HCAI Comparison

XBIO vs HCAI Comparison

Compare XBIO & HCAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xenetic Biosciences Inc.

XBIO

Xenetic Biosciences Inc.

HOLD

Current Price

$3.15

Market Cap

7.2M

Sector

Health Care

ML Signal

HOLD

HCAI

Huachen AI Parking Management Technology Holding Co. Ltd. Ordinary Shares

HOLD

Current Price

$11.75

Market Cap

7.7M

ML Signal

HOLD

Company Overview

Basic Information
Metric
XBIO
HCAI
Founded
N/A
2004
Country
United States
China
Employees
2
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Miscellaneous manufacturing industries
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
7.2M
7.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
XBIO
HCAI
Price
$3.15
$11.75
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
14.2K
1.5M
Earning Date
05-13-2026
05-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$2.81
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$63.07
Revenue Growth
N/A
N/A
52 Week Low
$1.90
$0.13
52 Week High
$13.93
$25.99

Technical Indicators

Market Signals
Indicator
XBIO
HCAI
Relative Strength Index (RSI) 53.48 58.74
Support Level $2.94 $0.37
Resistance Level $3.69 $25.99
Average True Range (ATR) 0.15 3.29
MACD -0.02 0.15
Stochastic Oscillator 52.38 31.51

Price Performance

Historical Comparison
XBIO
HCAI

About XBIO Xenetic Biosciences Inc.

Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing immuno-oncology technologies addressing difficult-to-treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors. Its product pipeline consists of two key programs, XBIO-015 and XBIO-020, which are being developed to address pancreatic carcinoma and solid tumours.

About HCAI Huachen AI Parking Management Technology Holding Co. Ltd. Ordinary Shares

Huachen AI Parking Management Technology Holding Co Ltd is a comprehensive smart parking solutions and equipment structural parts provider. The company manufactures and offer various cubic parking garage products by employing various working principles, such as lifting and shifting, convenient lifting, vertical circulation, vertical lifting, plane moving, alley stacking, multi-layer cycle, horizontal cycle, and car lift.

Share on Social Networks: